Semaglutide and tirzepatide are the most effective weight loss medications ever developed. But a prescription without a protocol is a missed opportunity.
Dr. Seth Lampert manages every aspect of your GLP-1 therapy: labs, dosing, side effects, and body composition — so you get safe, sustainable results.
Dr. Seth Lampert, MDFounding Physician and Medical Director
Tufts University School of Medicine
No rotating providers, no nurse practitioner handoffs. Dr. Lampert is your physician from first evaluation through maintenance.
Your physician tracks metabolic markers, thyroid function, nutrient levels, and body composition. The goal is fat loss with muscle preserved.
New medications, new formulations, new combination therapies. Your protocol reflects the best available evidence, not what was standard two years ago.
Complete your intake. Dr. Lampert reviews your history and orders the baseline testing appropriate for your goals. Then a comprehensive video consultation: lab review, medication selection, and your treatment plan.
Your prescription is sent. Treatment begins with a titration schedule tailored to your body. Your physician is a message away if anything comes up.
Regular check-ins, lab reviews, dose adjustments, and body composition tracking. Real protocol management by someone who knows your case.
Nausea, GI issues, fatigue — these are signals, not inconveniences. Dr. Lampert adjusts your dose, changes your titration schedule, or switches medications based on how you're actually responding. You're not submitting a support ticket and waiting.
Semaglutide and tirzepatide are not interchangeable. Your medical history, metabolic profile, and how your body responds should drive the choice. That decision requires a physician, not a form.
GLP-1s shift metabolic markers significantly. He orders labs before you start, monitors them as you go, and uses that data to guide your treatment. If something's improving, you'll know. If something needs attention, he'll catch it.
Muscle loss is one of the real risks of rapid weight loss on GLP-1s. Your physician tracks body composition and builds your protocol around preserving lean mass, not just watching the scale drop.
Most people who stop GLP-1 therapy regain the weight. A physician who knows your full history can build a real maintenance strategy: tapering, dosing adjustments, or continued treatment. Not just refilling until you cancel.
Dr. Lampert prescribes the full range of FDA-approved medications based on your metabolic profile, insurance situation, and clinical goals.
The original GLP-1 breakthrough. 15-17% average body weight loss in clinical trials. Weekly injection with the most established safety profile in the class.
Dual GLP-1/GIP receptor agonist. Up to 22.5% average weight loss in trials. Often the better choice for patients who need significant metabolic intervention.
Daily oral tablet for patients who prefer not to inject. Effective for weight management, though typically with more modest results than injectable formulations.
Next-generation oral semaglutide, amycretin, survodutide, and other agents advancing through FDA review. Available to patients as they gain approval.
"The difference between a prescription and a physician."
Wellesley Medical
Medications purchased separately through your pharmacy, insurance, or manufacturer savings programs.
Wellesley Medical currently serves patients in Massachusetts and Rhode Island via telehealth.
Semaglutide (Ozempic, Wegovy) targets the GLP-1 receptor. Tirzepatide (Mounjaro, Zepbound) targets both GLP-1 and GIP receptors. Clinical trials show tirzepatide produces greater average weight loss, but individual response varies. Dr. Lampert evaluates your metabolic profile, medication history, and goals to determine which is right for you.
Most online platforms run a checkbox intake, prescribe a standard titration schedule, and respond to side effects reactively through async tickets. Dr. Lampert takes a full medical history, orders the baseline testing appropriate for your profile, chooses the right medication for your profile, actively manages titration and side effects, monitors body composition, and builds a plan for what happens after you reach your goal. You see the same physician every time.
Yes. Dr. Lampert prescribes all FDA-approved GLP-1 and dual-receptor agonist medications, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and newer agents as they receive approval.
The initial evaluation is $600 one-time. Ongoing care is $350 per month, cancel anytime. This covers all physician consultations, lab interpretation, medication management, and ongoing monitoring. Medications are purchased separately through your pharmacy or manufacturer savings programs.
The GLP-1 landscape is evolving rapidly. Dr. Lampert actively follows the latest clinical research and regulatory approvals. As new options become available, your protocol can evolve to include the most effective treatments.